1. Home
  2. SUPN vs BB Comparison

SUPN vs BB Comparison

Compare SUPN & BB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • BB
  • Stock Information
  • Founded
  • SUPN 2005
  • BB 1984
  • Country
  • SUPN United States
  • BB Canada
  • Employees
  • SUPN N/A
  • BB N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • BB
  • Sector
  • SUPN Health Care
  • BB
  • Exchange
  • SUPN Nasdaq
  • BB Nasdaq
  • Market Cap
  • SUPN 2.6B
  • BB 2.7B
  • IPO Year
  • SUPN 2012
  • BB 1997
  • Fundamental
  • Price
  • SUPN $54.61
  • BB $4.79
  • Analyst Decision
  • SUPN Strong Buy
  • BB Hold
  • Analyst Count
  • SUPN 3
  • BB 6
  • Target Price
  • SUPN $62.67
  • BB $4.98
  • AVG Volume (30 Days)
  • SUPN 725.2K
  • BB 11.1M
  • Earning Date
  • SUPN 11-04-2025
  • BB 09-25-2025
  • Dividend Yield
  • SUPN N/A
  • BB N/A
  • EPS Growth
  • SUPN 1411.53
  • BB N/A
  • EPS
  • SUPN 1.14
  • BB N/A
  • Revenue
  • SUPN $665,125,000.00
  • BB $536,600,000.00
  • Revenue This Year
  • SUPN $7.31
  • BB $2.43
  • Revenue Next Year
  • SUPN $21.87
  • BB $7.41
  • P/E Ratio
  • SUPN $46.18
  • BB N/A
  • Revenue Growth
  • SUPN 5.55
  • BB N/A
  • 52 Week Low
  • SUPN $29.16
  • BB $2.24
  • 52 Week High
  • SUPN $53.28
  • BB $6.24
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 78.22
  • BB 60.19
  • Support Level
  • SUPN $49.95
  • BB $4.45
  • Resistance Level
  • SUPN $52.15
  • BB $4.86
  • Average True Range (ATR)
  • SUPN 1.36
  • BB 0.22
  • MACD
  • SUPN 0.30
  • BB -0.01
  • Stochastic Oscillator
  • SUPN 97.61
  • BB 61.17

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About BB BlackBerry Limited

BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.

Share on Social Networks: